Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.55 |
| ▸ | SQLE | Q14534 | 4/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8319131 | 1.00 | PTPN1 (0.69) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL27414779 | 0.98 | PTPN1 (0.72) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL27414782 | 0.95 | ALOX15 (0.65) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL17244805 | 0.95 | ALOX15 (0.65) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL27414783 | 0.95 | ALOX15 (0.65) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL28885971 | 0.94 | PTPN1 (0.66) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| SCHEMBL27414780 | 0.88 | PTPN1 (0.83) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| Trans-Phytol SCHEMBL4063116 | 0.85 | PTPN1 (0.79) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| Trans-Phytol SCHEMBL2066043 | 0.85 | PTPN1 (0.79) | PTPN1ALOX15ALDH1A1KMT2AMEN1 | |
| Squalene SCHEMBL29131843 | 0.84 | PTPN1 (0.77) | PTPN1ALOX15ALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12365905-B2 | Host cells and methods for reducing isoprenoid precursors and isoprenoids by geranylgeranyl reductase | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-22 | — | — | US | disclosed |
| US-20240209132-A1 | COUPLING OF 2,3,5-TRIMETHYLHYDROQUINONE AND UNSATURATED ALCOHOLS | DSM IP ASSETS B.V. (NL) | 2024-06-27 | — | — | US | disclosed |
| US-20220396823-A1 | COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION | TUMOREND, LLC (US) | 2022-12-15 | — | — | US | disclosed |
| US-11203776-B2 | Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration | TUMOREND, LLC (US) | 2021-12-21 | — | — | US | disclosed |
| US-20200255841-A1 | HOST CELLS AND METHODS FOR REDUCING ISOPRENOID PRECURSORS AND ISOPRENOIDS BY GERANYLGERANYL REDUCTASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-08-13 | — | — | US | disclosed |
| US-20190017095-A1 | COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION | TUMOREND, LLC (US) | 2019-01-17 | — | — | US | disclosed |
| WO-2016077567-A1 | COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION | TUMOREND, LLC (US) | 2016-05-19 | — | — | WO | disclosed |
| US-20130158106-A1 | TOCOPHEROL DERIVATIVES AND METHODS OF USE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS (US) | 2013-06-20 | — | — | US | disclosed |
| US-20130158106-A1 | TOCOPHEROL DERIVATIVES AND METHODS OF USE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS (US) | 2013-06-20 | — | — | US | disclosed |
| EP-1793796-B1 | USE OF AROMA SUBSTANCE MIXTURES AS AGENTS AGAINST BAD BREATH | SYMRISE GMBH & CO KG (DE) | 2009-12-09 | — | — | EP | disclosed |
| US-20070218016-A1 | Use of Aroma Substance Mixtures as Agents Against Bad Breath | SYMRISE GMBH & CO. KG (DE) | 2007-09-20 | — | — | US | disclosed |
| EP-0258967-B2 | Process for producing optically active alcohols | TAKASAGO PERFUMERY CO LTD (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-4962242-A | HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX | TAKASAGO PERFUMERY CO., LTD. (JP) | 1990-10-09 | — | — | US | disclosed |
| EP-0258967-A2 | Process for producing optically active alcohols | Takasago Perfumery Co., Ltd. (JP) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396823-A1 | COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION | SIGLEC7, SIGLEC9, HAVCR2 | PTPN1 1410/4885ALOX15 592/4885ALDH1A1 1675/4885 |
| US-11203776-B2 | Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration | SIGLEC7, SIGLEC9, HAVCR2 | PTPN1 1410/4885ALOX15 592/4885ALDH1A1 1675/4885 |
| US-20130158106-A1 | TOCOPHEROL DERIVATIVES AND METHODS OF USE | TTPA, OSBP, PCTP | PTPN1 4876/4885ALOX15 267/4885ALDH1A1 1927/4885 |
| US-20190017095-A1 | COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION | SIGLEC7, SIGLEC9, HAVCR2 | PTPN1 1410/4885ALOX15 592/4885ALDH1A1 1675/4885 |
| US-20070218016-A1 | Use of Aroma Substance Mixtures as Agents Against Bad Breath | BAD, BAX, BAK1 | PTPN1 4340/4885ALOX15 2594/4885ALDH1A1 2448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.